Loading news...
Artisan Partners Limited Partnership lowered its position in Cencora, Inc. (NYSE: COR) by 6.8% in the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm owned 1,279,587 shares of the company's stock after selling 94,061 shares during the quarter. Artisan Partners Limited Partnership owned 0.66%
Lansforsakringar Fondforvaltning AB publ increased its holdings in Cencora, Inc. (NYSE: COR) by 5.4% during the undefined quarter, according to its most recent Form 13F filing with the SEC. The fund owned 60,254 shares of the company's stock after purchasing an additional 3,073 shares during the period. Lansforsakringar Fondforvaltning AB publ's holdings in
Bleakley Financial Group LLC lessened its stake in shares of Cencora, Inc. (NYSE: COR) by 15.3% in the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 21,347 shares of the company's stock after selling 3,867 shares during the period.
Cencora is set to merge MWI Animal Health with Covetrus in a $3.5B deal, retaining a 34.3% stake as it unlocks capital and targets animal health growth.
Public Sector Pension Investment Board raised its holdings in Cencora, Inc. (NYSE: COR) by 54.8% in the undefined quarter, according to its most recent 13F filing with the SEC. The fund owned 18,187 shares of the company's stock after acquiring an additional 6,442 shares during the period. Public Sector Pension Investment Board's holdings
Drug distributor Cencora will merge its MWI Animal Health unit with privately held Covetrus in a deal that values MWI at $3.5 billion, the companies said on Wednesday.
CONSHOHOCKEN, Pa. & PORTLAND, Maine--(BUSINESS WIRE)--Cencora (NYSE: COR) and Covetrus, a global animal health technology and services company, today announced that they have entered into a definitive agreement under which Covetrus and MWI Animal Health (MWI) will merge, creating a combined company offering a comprehensive animal health platform. “Our mission has always been to empower veterinary practices to work smarter and deliver better care,” said Ben Wolin, President and Chief Executive O.
Investors need to pay close attention to COR stock based on the movements in the options market lately.
Assetmark Inc. increased its holdings in shares of Cencora, Inc. (NYSE: COR) by 23.0% in the third quarter, according to its most recent filing with the SEC. The fund owned 42,850 shares of the company's stock after acquiring an additional 8,016 shares during the period. Assetmark Inc.'s holdings in Cencora were worth $13,392,000
Aberdeen Group plc grew its position in Cencora, Inc. (NYSE: COR) by 5.4% during the third quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 158,564 shares of the company's stock after purchasing an additional 8,076 shares during the quarter. Aberdeen Group plc
CENTRAL TRUST Co boosted its stake in shares of Cencora, Inc. (NYSE: COR) by 116.0% in the undefined quarter, according to the company in its most recent disclosure with the SEC. The firm owned 3,500 shares of the company's stock after buying an additional 1,880 shares during the quarter. CENTRAL TRUST Co's holdings
CONSHOHOCKEN, Pa.--(BUSINESS WIRE)--Cencora, Inc. (NYSE: COR) today announced the closing of its public offering of $500 million aggregate principal amount of its 3.950% Senior Notes due February 13, 2029 (the “2029 Notes”), $500 million aggregate principal amount of its 4.250% Senior Notes due November 15, 2030 (the “2030 Notes”), $500 million aggregate principal amount of its 4.600% Senior Notes due February 13, 2033 (the “2033 Notes”), $1.0 billion aggregate principal amount of its 4.900% Se.
Atria Investments Inc lessened its position in shares of Cencora, Inc. (NYSE: COR) by 7.0% in the undefined quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 48,761 shares of the company's stock after selling 3,693 shares during the period. Atria Investments Inc's holdings in
CONSHOHOCKEN, Pa.--(BUSINESS WIRE)--Cencora, Inc. (NYSE: COR) today announced that it priced $500 million aggregate principal amount of its 3.950% Senior Notes due February 13, 2029 (the “2029 Notes”), $500 million aggregate principal amount of its 4.250% Senior Notes due November 15, 2030 (the “2030 Notes”), $500 million aggregate principal amount of its 4.600% Senior Notes due February 13, 2033 (the “2033 Notes”), $1.0 billion aggregate principal amount of its 4.900% Senior Notes due February.
BI Asset Management Fondsmaeglerselskab A S lifted its position in shares of Cencora, Inc. (NYSE: COR) by 17.9% during the third quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 144,287 shares of the company's stock after purchasing an additional 21,933 shares during the period. BI
Adjusted Diluted EPS: $4.08, an increase of 9%.Consolidated Revenue: $85.9 billion, up 5.5%.Consolidated Gross Profit: $3.0 billion, up 18%.Gross Profit Margin
Cencora, Inc. (COR) Q1 2026 Earnings Call Transcript
COR shares slip despite Q1 EPS beat and revenues match estimates, margins expand and fiscal 2026 growth guidance up.
Cencora reported higher Q1 earnings but missed revenue estimates, driven by U.S. and European drug sales growth.
The headline numbers for Cencora (COR) give insight into how the company performed in the quarter ended December 2025, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.